Notify me when ForGrowth III PA B.V. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VOR | VOR BIOPHARMA INC. | Common Stock, $0.0001 par value per share | 10% | $81,492,203 | +$25,772,203 | 10,237,714 | +46% | ForGrowth III PA B.V. | 18 Dec 2025 |
| RAPT | RAPT Therapeutics, Inc. | Common Stock $0.0001 par value per share | 7.4% | $47,291,008 | 1,833,333 | ForGrowth III PA B.V. | 23 Oct 2025 | ||
| CBIO | Crescent Biopharma, Inc. | Ordinary Shares, $0.001 par value per share | 6.1% | $21,778,519 | 1,677,852 | ForGrowth III PA B.V. | 08 Dec 2025 | ||
| ATXS | Astria Therapeutics, Inc. | Common Stock, $0.001 par value per share | 0% | $0 | -$27,828,069 | 0 | -100% | ForGrowth III PA B.V. | 16 Oct 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|